by Truveta Research | Feb 4, 2025 | Research, Research Insights
Mental health prescribing remained relatively stable since 2018. Prescription rates for antidepressants, mood stabilizers, and antipsychotics peaked between 2020 and 2022 but have since stabilized or slightly declined compared to 2018 rates. Anxiolytic prescriptions...
by Truveta staff | Jan 31, 2025 | Research
Discontinuation within one year was significantly higher in patients without T2D (64.8%) compared to those with T2D (46.5%). When patients experienced greater weight loss, they were less likely to discontinue the GLP-1 RA medications. Among patients with T2D, higher...
by Truveta staff | Jan 21, 2025 | Research
Overall, the rate of hospitalizations associated with respiratory viruses increased 3-fold between the end of November and end of December (209.2% increase). Respiratory viruses now are associated with 9.3% of all hospitalizations. Rates of influenza-associated...
by Truveta Research | Dec 21, 2024 | Research, Research Insights
In an exclusive analysis for the Wall Street Journal, Truveta Research explored mental health-related emergency department visits. The rate of ED encounters related to mental health conditions peaked in 2021 for all conditions studied, besides schizophrenia, which...
by Truveta staff | Dec 19, 2024 | Research
Between the last week of October and the last week of November, there was a 58.8% increase in respiratory virus-associated hospitalizations. For infants and children under the age of 5, respiratory viruses are now associated with 7.9% of hospitalizations in this...
by Truveta Research | Dec 16, 2024 | Research, Research Insights
In partnership with Reuters, Truveta Research explored the percentage of patients who received a first-time diagnosis of type 2 diabetes, cardiovascular disease, or sleep apnea within 15 days of their first-time GLP-1 prescriptions. Truveta Research found that for...
